Form 4: Precision BioSciences Executive Acquires Restricted Stock Units
SEC Form 4 Filing
Dario Scimeca, General Counsel and Secretary of Precision BioSciences, acquired 44,723 restricted stock units on August 22, 2024, which vest annually starting January 20, 2025.
Summary
- Dario Scimeca, the General Counsel and Secretary of Precision BioSciences, filed a Form 4 on August 23, 2024.
- The filing reports the acquisition of 44,723 restricted stock units (RSUs) on August 22, 2024.
- These RSUs represent a contingent right to receive one share of Precision BioSciences' common stock each.
- The award vests in three substantially equal annual installments beginning on January 20, 2025, contingent upon Scimeca's continued service to the company.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating an executive's compensation in the form of stock units. It doesn't inherently suggest positive or negative performance, but rather a standard practice.
Positives
- The acquisition of restricted stock units by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of the restricted stock units is contingent upon the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Industry Context
This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company executives.
Stakeholder Impact
- The acquisition of restricted stock units by a key executive could potentially increase shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Date of transaction: Dario Scimeca acquired 44,723 restricted stock units. |
| 08/23/2024 | Date of filing: Form 4 was filed. |
| 01/20/2025 | First vesting date: The restricted stock units vest in three substantially equal annual installments beginning on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.